Educational campaign to target unclear drug notations
The U.S. Food and Drug Administration and the Institute for Safe Medication Practices will launch an educational campaign next year in an effort to reduce medication errors that result from ambiguous abbreviations and dose designations on prescriptions.
By Michael Romano
November 9, 2005